niedziela, 3 czerwca 2012

Esophageal cancer prognosis: Study cites new treatment options

(HealthDay News) -- For patients with esophageal or esophagogastric-junction cancer, treatment with neoadjuvant chemoradiotherapy followed by surgical resection is associated with improved survival compared with surgery alone, according to a studyA study of the FDA adverse event reporting system disclosed more cases of esophageal cancer in association with bisphosphonate use than previously described. No.Scientists have uncovered new clues about whether cancer is the next step on this road. Esophageal cancer more commonly develops when GERD and inflammation band together to do their

Read more ...

Brak komentarzy:

Prześlij komentarz